J Oncol Pharm Pract
October 2022
Introduction: To evaluate biosimilar understanding and preference trends of medical oncologists in Turkey.
Methods: A survey consisting of 24 multiple-choice questions with checkbox answers was conducted among medical oncologists. The questionnaire was divided into five parts to some intentions: demographic characteristics, general knowledge about biosimilars, knowledge about local approval and reimbursement issues, individual preference trends, and ranking the knowledge of their own.